Loading...

Shandong Weigao Group Medical Polymer Company Limited

1066.HKHKSE
Healthcare
Medical - Instruments & Supplies
HK$6.06
HK$-0.11(-1.78%)

Shandong Weigao Group Medical Polymer Company Limited 1066.HK Peers

See (1066.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Instruments & Supplies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
1066.HKHK$6.06-1.78%27.4B12.37HK$0.49+3.89%
2276.HKHK$37.55-0.92%17.5B33.23HK$1.13+0.38%
6699.HKHK$57.65-1.71%9.8B104.82HK$0.55+2.35%
9997.HKHK$7.73-2.52%9.1B14.31HK$0.54+3.70%
1501.HKHK$25.50-0.58%4.6B21.25HK$1.20N/A
3600.HKHK$4.26N/A4B9.91HK$0.43+4.04%
6929.HKHK$3.56-0.56%2.9B9.37HK$0.38+2.81%
1358.HKHK$1.13+5.61%1.7B10.27HK$0.11+8.36%
1942.HKHK$0.51+5.15%583.2M-2.55-HK$0.20N/A
1120.HKHK$1.08+6.93%417.2M36.00HK$0.03N/A
Showing 1 to 10 of 13 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

1066.HK vs 2276.HK Comparison

1066.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1066.HK stands at 27.4B. In comparison, 2276.HK has a market cap of 17.5B. Regarding current trading prices, 1066.HK is priced at HK$6.06, while 2276.HK trades at HK$37.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1066.HK currently has a P/E ratio of 12.37, whereas 2276.HK's P/E ratio is 33.23. In terms of profitability, 1066.HK's ROE is +0.09%, compared to 2276.HK's ROE of +0.25%. Regarding short-term risk, 1066.HK is more volatile compared to 2276.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1066.HK.

Stock Price Comparison

Loading...

Frequently Asked Questions